Nvelop Therapeutics

Cambridge, United States

Nvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.

$100.0M raised

Sep 2023

Seed

Biotechnology Genetics Medical

Top Investors

5AM Ventures F-Prime Atlas Venture Newpath Management

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Nvelop Therapeutics

How much funding has Nvelop Therapeutics raised?

Nvelop Therapeutics has raised $100.0M in total funding. The most recent round was Seed. The last funding was announced in September 2023.

Who are Nvelop Therapeutics's investors?

Nvelop Therapeutics's investors include 5AM Ventures, F-Prime, Atlas Venture, Newpath Management.

Where is Nvelop Therapeutics headquartered?

Nvelop Therapeutics is headquartered in Cambridge, United States.

What does Nvelop Therapeutics do?

Nvelop Therapeutics is a biotechnology company that developes genetic medicines for patients with severe genetic diseases.

What stage is Nvelop Therapeutics at?

Nvelop Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 20, 2023.

MLA

"Nvelop Therapeutics — Funding & Investors." VCBacked, September 20, 2023, https://www.vcbacked.co/company/nvelop-therapeutics. Accessed July 2, 2026.

APA

VCBacked. (2023). Nvelop Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nvelop-therapeutics

Wikipedia (cite web)

{{cite web |title=Nvelop Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/nvelop-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 20, 2023.